Dianthus Therapeutics, Inc. (DNTH) stock
DNTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$92.48+3.18 (+3.56%)
Close on Nov 12, 2026Market cap $5.17BP/E –Yield 0.00%
Dianthus Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Dianthus Therapeutics's profit margin for the twelve months ending Dec 31, 2025 was -7973.3%. For fiscal 2025 it was -7973.3%, against -1362.8% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -7973.3% | −6610.6 |
| FY2024 | Dec 31, 2024 | -1362.8% | +178.4 |
| FY2023 | Dec 31, 2023 | -1541.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -22687.3% | −20542.5 |
| Q3 FY2025 | Sep 30, 2025 | -9284.1% | −8125.1 |
| Q2 FY2025 | Jun 30, 2025 | -16388.1% | −15443.0 |
| Q1 FY2025 | Mar 31, 2025 | -2537.5% | −964.5 |
| Q4 FY2024 | Dec 31, 2024 | -2144.8% | +166.6 |
| Q3 FY2024 | Sep 30, 2024 | -1159.0% | +438.7 |
| Q2 FY2024 | Jun 30, 2024 | -945.1% | −281.5 |
| Q1 FY2024 | Mar 31, 2024 | -1573.0% | – |
| Q4 FY2023 | Dec 31, 2023 | -2311.4% | – |
| Q3 FY2023 | Sep 30, 2023 | -1597.7% | – |
| Q3 FY2022 | Sep 30, 2022 | -663.6% | – |
See a number that looks wrong?